GlassScriptPhysician profile
Luis Rosario
NPI 1245203793
$4,361.07
in general payments reported to CMS, 2019-2025
5 companies · $3,720 in 2025
The $3,720 reported for 2025 was more than what 95% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
See the full distribution for Oral and Maxillofacial Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $82.33 · 2020: $68.24 · 2021: $159 · 2022: $14.31 · 2023: $88.14 · 2024: $229 · 2025: $3,720.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,058 · Food and Beverage: $1,729 · Gift: $250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,057.60 |
| Food and Beverage | $1,729.47 |
| Gift | $250.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $4,282.40 | 2019-2025 | |
| Nobel Biocare USA | $35.72 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $21.57 | 2020 | |
| Carestream Dental, LLC | $13.89 | 2021 | |
| Kls-Martin L.P. | $7.49 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Rosario listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.